The GLP-1 Analogue Liraglutide Protects Cardiomyocytes from High Glucose-induced Apoptosis by Activating the Epac-1/Akt Pathway

Conclusions: Liraglutide protects cardiomyocytes from high glucose-induced apoptosis by activating the Epac-1/Akt pathway.[...]© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents  |  Abstract  |  Full text

Source: Experimental and Clinical Endocrinology and Diabetes - August 20, 2014 Category: Endocrinology Authors: Wu, X.-M.Ou, Q.-Y.Zhao, W.Liu, J.Zhang, H. Tags: Article Source Type: research